161 First Street
About CrestovoCrestovo was launched to advance the years of foundational clinical research and development of the company’s founder and scientific advisor Dr. Thomas J. Borody, and academic collaborators, Dr. Alexander Khoruts and Dr. Michael Sadowsky. Their collective work has validated orally-administered, full-spectrum bacterial composition products across a variety of serious diseases and medical needs, including recurrent Clostridium difficile infection (CDI, also commonly referred to as C. difficile or C. diff).
Thomas J. Borody, M.D.
Interim CEO & COO: Joseph Lobacki
Please click here for Crestovo's job opportunities.
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.